tiprankstipranks
Trending News
More News >
Protect Pharmaceutical Corporation (PRTT)
OTHER OTC:PRTT
US Market

Protect Pharmaceutical (PRTT) Income Statement

Compare
17 Followers

Protect Pharmaceutical Income Statement

Last quarter (Q2 2025), Protect Pharmaceutical's total revenue was $26.34M, a decrease of -42.05% from the same quarter last year. In Q2, Protect Pharmaceutical's net income was $6.63M. See Protect Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 132.26M$ 136.16M$ 81.80M$ 78.79M$ 5.94M
Gross Profit
$ 72.56M$ 73.31M$ 41.58M$ 44.37M$ 5.86M
Operating Expenses
$ 14.92M$ 25.77M$ 16.32M$ 16.49M$ 48.11K
Depreciation and Amortization
$ 0.00$ 167.90K$ 228.49K$ 236.56K$ 206.30K
EBITDA
$ 57.64M$ 47.71M$ 25.49M$ 28.11M$ 5.81M
Operating Income
$ 57.64M$ 47.54M$ 25.26M$ 27.88M$ 5.81M
Other Income/Expenses
$ 0.00$ 0.00$ 0.00$ 0.00$ -1.37K
Pretax Income
$ 57.64M$ 47.54M$ 25.26M$ 27.88M$ 5.81M
Net Income
$ 56.33M$ 45.91M$ 22.44M$ 20.21M$ 5.81M
Per Share Metrics
Basic EPS
$ 0.98$ 0.80$ 0.43$ 0.36$ 0.11
Diluted EPS
$ 0.98$ 0.80$ 0.43$ 0.36$ 0.11
Weighted Average Shares Outstanding
57.45M 57.45M 52.78M 56.25M 54.95M
Weighted Average Shares Outstanding (Diluted)
57.45M 57.45M 52.78M 56.25M 54.95M
Currency in USD

Protect Pharmaceutical Earnings and Revenue History